Reduced fecal intestinal alkaline phosphatase is associated with gestational diabetes mellitus: A hospital-based multicentre cross-sectional study in Bangladesh
Chowdhury, P.; Tofail, T.; Akter, N.; Islam, H.; Bokshi, A.; Sultana, M.; Podder, S.; Malo, M. S.; Hasanat, M.
Show abstract
Gestational diabetes mellitus (GDM) is a major metabolic complication of pregnancy with significant maternal and fetal adverse consequences. Beyond classical mechanisms, emerging evidence suggests that gut-derived metabolic endotoxemia may contribute to dysglycemia. Intestinal alkaline phosphatase (IAP), a key enzyme involved in maintaining gut barrier integrity and detoxifying lipopolysaccharides, has been linked to type 2 diabetes mellitus; however, its role in GDM remains largely unexplored. This hospital-based cross-sectional analytical study evaluated fecal IAP levels and their association with GDM among 198 pregnant women recruited from three antenatal care clinics representing three tiers of ANC services. Participants were screened for GDM using a 75-g oral glucose tolerance test and classified as having GDM (n=55) or normal glucose tolerance (NGT; n=143) according to WHO 2013 criteria. Stool samples were collected, and fecal IAP levels were measured using an enzymatic colorimetric assay. Fecal IAP level was significantly lower in women with GDM than in those with NGT (median 23.59 vs 46.48 U/g stool; p<0.001). Lower IAP level remained independently associated with GDM after adjustment for body mass index and previous GDM (adjusted OR 0.98 per unit increase; 95% CI 0.97-0.99; p<0.001). A graded relationship was observed between declining IAP level and GDM. Receiver operating characteristic analysis demonstrated modest discrimination (AUC 0.676), while a threshold of approximately 65 U/g stool yielded high sensitivity (89.1%) but lower specificity. Reduced fecal IAP is independently associated with GDM, supporting a potential role of gut-derived metabolic dysregulation in gestational glucose intolerance. While not suitable as a standalone diagnostic tool, fecal IAP may serve as a complementary biomarker for risk stratification during pregnancy. Prospective studies are warranted to determine its predictive value and explore its potential as a therapeutic target.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Early postpartum HbA1c after hyperglycemia first detected in pregnancy - imperfect but not without value 97%
- The relationship between maternal glucose concentrations, gestational diabetes mellitus, placental weight, and placental vascular malperfusion lesions: a retrospective study of a U.S. pregnancy cohort 95%
- Determinants of glycemic control among persons living with type 2 diabetes mellitus attending a district hospital in Ghana 94%
Similar papers in this journal
Similar papers in this journal
- Influence of parental anthropometry and gestational weight gain on intrauterine growth and neonatal outcomes: Findings from the MAI cohort study in rural India 93%
- Prevalence of metabolic dysfunction-associated fatty liver disease and its association with glycemic control in persons with type 2 diabetes in Africa: a systematic review and meta-analysis 93%
- Unusual patterns of risk for diabetic retinopathy in the Mumbai slums: The Aditya Jyot Diabetic Retinopathy in Urban Mumbai Slums Study (AJ-DRUMSS) Report 3 93%
Similar papers in this journal
- The Relationship Between Clinical Profile, Glycemic Parameters And Hypoglycemia In Type 1 Diabetes Pediatric Patients 94%
- Polycystic ovary syndrome susceptibility loci inform disease etiological heterogeneity 93%
- The development of a multidisciplinary care pathway for patients with inflammatory bowel disease before, during and after pregnancy 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.